Market Overview
Structural heart imaging encompasses echocardiography, cardiac magnetic resonance imaging, computed tomography, and other modalities used to diagnose and guide interventions for structural heart diseases. The North American market, led by the United States, benefits from advanced healthcare infrastructure and high adoption rates of innovative imaging technologies across hospital and outpatient settings.
- •Market valued at approximately $0.75 billion in North America in 2025
- •Driven by rising prevalence of valvular heart disease and structural cardiac conditions
- •Strong adoption of advanced imaging in cardiac catheterization labs and imaging centers
Growth Drivers
An aging population with increasing incidence of structural heart disease is a primary catalyst, as older adults face higher risks of valve dysfunction and congenital complications. Technological advances in 3D imaging, image fusion, and portable echocardiography devices are expanding clinical utility and market reach. Growing preference for minimally invasive transcatheter procedures requiring precise imaging guidance further fuels demand.
- •Aging U.S. population driving increased prevalence of aortic stenosis and mitral valve disease
- •Expansion of transcatheter aortic valve replacement and other minimally invasive structural interventions
- •Integration of artificial intelligence in image analysis improving diagnostic accuracy and workflow efficiency
Segmentation and Regional Analysis
The U.S. dominates the North American structural heart imaging market, supported by favorable reimbursement policies, high healthcare expenditure, and widespread availability of advanced imaging equipment. Echocardiography represents the largest segment due to its established role in initial diagnosis and procedural guidance. Hospital cardiology departments and imaging centers constitute the primary end-users, with growing adoption in ambulatory surgical centers.
- •Echocardiography leads the modality mix, followed by cardiac MRI and CT angiography
- •Hospital-based imaging centers account for the majority of market revenue
- •United States represents over 90% of the North American regional market share
Trends and Outlook
What are the recent trends and outlook?
Emerging trends include the integration of multimodality imaging fusion, point-of-care cardiac ultrasound expansion, and growing emphasis on quantitative imaging biomarkers for treatment planning. The market is expected to maintain steady 5.3% annual growth through the forecast period, supported by continued procedural volume increases and technological innovation. Future growth may be influenced by new regulatory approvals for advanced imaging software and expanding indications for structural heart interventions.
- •AI-assisted image interpretation gaining regulatory clearance and clinical acceptance
- •Hybrid operating rooms with integrated imaging systems becoming standard in advanced cardiac centers
- •Projected sustained growth driven by TAVR and other transcatheter structural heart procedure volume increases
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.